|

Insulin Degludec Injection Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 1: 2

Top Sponsors

  • The United Bio-Technology (Hengqin) Co., Ltd.1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Diabetes2
  • Type 2 Diabetes Mellitus (T2DM)1
  • Type 2 Diabetes1

Other2 trials

A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
Phase 1
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.